PortfoliosLab logo

SPDR S&P Pharmaceuticals ETF

XPH
ETF · Currency in USD
ISIN
US78464A7220
CUSIP
78464A722
Issuer
State Street
Inception Date
Jun 19, 2006
Region
North America (U.S.)
Category
Health & Biotech Equities
Expense Ratio
0.35%
Index Tracked
S&P Pharmaceuticals Select Industry Index
ETF Home Page
www.etf.com
Asset Class
Equity

Asset Class Size

Multi-Cap

Asset Class Style

Blend

XPHPrice Chart


Chart placeholderClick Calculate to get results

XPHPerformance

The chart shows the growth of $10,000 invested in SPDR S&P Pharmaceuticals ETF on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $30,811 for a total return of roughly 208.11%. All prices are adjusted for splits and dividends.


XPH (SPDR S&P Pharmaceuticals ETF)
Benchmark (S&P 500)

XPHReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M1.74%
6M-2.34%
YTD-7.39%
1Y6.52%
5Y3.23%
10Y9.25%

XPHMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

XPHSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current SPDR S&P Pharmaceuticals ETF Sharpe ratio is 0.25. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


XPH (SPDR S&P Pharmaceuticals ETF)
Benchmark (S&P 500)

XPHDividends

SPDR S&P Pharmaceuticals ETF granted a 0.63% dividend yield in the last twelve months, as of Oct 23, 2021. The annual payout for that period amounted to $0.30 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$0.30$0.25$0.29$0.24$0.29$0.25$3.66$3.00$0.91$0.53$0.29$0.26

Dividend yield

0.63%0.47%0.64%0.65%0.67%0.63%7.15%5.55%2.06%1.90%1.14%1.12%

XPHDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


XPH (SPDR S&P Pharmaceuticals ETF)
Benchmark (S&P 500)

XPHWorst Drawdowns

The table below shows the maximum drawdowns of the SPDR S&P Pharmaceuticals ETF. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the SPDR S&P Pharmaceuticals ETF is 48.03%, recorded on Mar 23, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-48.03%Jul 23, 20151175Mar 23, 2020
-17.59%Jul 8, 201122Aug 8, 2011106Jan 9, 2012128
-14.51%Mar 6, 201428Apr 14, 201447Jun 20, 201475
-13.17%Sep 19, 201240Nov 15, 201263Feb 19, 2013103
-10.95%Apr 6, 201062Jul 1, 201050Sep 13, 2010112
-10.85%Jul 7, 201424Aug 7, 201428Sep 17, 201452
-10.61%Mar 20, 201529Apr 30, 201551Jul 14, 201580
-7.03%Sep 25, 201413Oct 13, 201411Oct 28, 201424
-6.56%Jan 19, 201140Mar 16, 201113Apr 4, 201153
-6.43%Apr 30, 201224Jun 1, 201212Jun 19, 201236

XPHVolatility Chart

Current SPDR S&P Pharmaceuticals ETF volatility is 11.28%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


XPH (SPDR S&P Pharmaceuticals ETF)
Benchmark (S&P 500)

Portfolios with SPDR S&P Pharmaceuticals ETF


Loading data...

More Tools for SPDR S&P Pharmaceuticals ETF